Bovine Babesiosis (Redwater Fever, Tick Fever) caused by Babesia bigemina and Babesia bovis

Bovine babesiosis, also known as redwater fever or tick fever, is a tick-borne hemoprotozoan disease of cattle caused by the intraerythrocytic apicomplexan parasites Babesia bigemina and Babesia bovis. The disease is characterized by fever, anemia, hemoglobinuria (red urine), jaundice, and in severe cases, cerebral signs and death. It is one of the most economically important tick-borne diseases of cattle worldwide, particularly in tropical and subtropical regions. The disease affects both dairy and beef cattle, with high morbidity and mortality in susceptible adult animals. In endemic areas, calves are often protected by maternal antibodies and develop premunity, while introduced susceptible cattle suffer severe clinical disease. The economic impact includes direct mortality, reduced milk production, weight loss, abortion, decreased fertility, and costs of tick control and treatment. The disease is a major constraint to livestock improvement programs in many developing countries.

The primary causative agents are Babesia bigemina and Babesia bovis, both intraerythrocytic protozoan parasites of the phylum Apicomplexa, order Piroplasmida, family Babesiidae. Babesia bigemina is a large piroplasm (4-5 μm) that typically appears as paired pear-shaped merozoites within erythrocytes, while Babesia bovis is a small piroplasm (1-2 μm) that appears as single or multiple small ring forms. Both species are transmitted by ixodid ticks of the genus Rhipicephalus (Boophilus) microplus, with Babesia bigemina also transmitted by Rhipicephalus annulatus and Rhipicephalus decoloratus. Transmission is transovarial in ticks, with larvae, nymphs, and adults capable of transmitting the parasites. Babesia bovis is transmitted by larvae, while Babesia bigemina is transmitted by nymphs and adults. The parasites undergo sexual reproduction in the tick gut and asexual multiplication in the salivary glands, culminating in sporozoites that are injected into the bovine host during tick feeding. In cattle, sporozoites invade erythrocytes and undergo asexual replication by binary fission, leading to erythrocyte lysis and release of merozoites that infect new erythrocytes. Babesia bovis is more virulent than Babesia bigemina, causing microvascular sequestration of infected erythrocytes in the brain, kidneys, and other organs, leading to cerebral babesiosis and multi-organ failure. Babesia bigemina causes primarily hemolytic anemia and hemoglobinuria.

Bovine babesiosis is endemic in tropical and subtropical regions where the tick vectors are present, including parts of Africa, Asia, Australia, Central and South America, and southern Europe. The disease is most prevalent in areas with high tick density, typically during warm, humid seasons. Bos taurus breeds (e.g., Holstein, Hereford) are more susceptible to severe clinical disease than Bos indicus breeds (e.g., Brahman, Sahiwal), which have evolved resistance to ticks and babesiosis. Age is a critical factor: calves under 6 months of age are often protected by maternal antibodies and develop mild or subclinical infections, while older cattle, especially those introduced from babesiosis-free areas, are highly susceptible and may suffer mortality rates of 50-90% in outbreaks. In endemic areas, cattle develop premunity (persistent low-level infection with immunity) and remain carriers, serving as reservoirs for ticks. Morbidity can reach 100% in susceptible herds, with mortality varying from 5% to 90% depending on the species and strain of Babesia, the immune status of the host, and the timeliness of treatment. Economic losses include death, abortion, reduced milk yield (up to 30-50% in lactating cows), weight loss, and increased veterinary and tick control costs. The disease is a major impediment to the introduction of improved cattle breeds into tropical regions.

The pathophysiology of bovine babesiosis is primarily due to the intraerythrocytic multiplication of Babesia parasites, leading to hemolysis and, in the case of Babesia bovis, microvascular sequestration. After inoculation of sporozoites by ticks, the parasites invade erythrocytes and undergo asexual replication, causing erythrocyte rupture and release of merozoites, which then infect new erythrocytes. This cycle leads to progressive hemolytic anemia, with packed cell volume (PCV) dropping to as low as 10-15% in severe cases. The hemolysis results in hemoglobinemia, hemoglobinuria, and jaundice due to increased bilirubin production. Babesia bovis additionally induces cytoadhesion of infected erythrocytes to vascular endothelium, particularly in the brain, kidneys, lungs, and skeletal muscle, leading to microvascular occlusion, ischemia, and tissue hypoxia. This sequestration is mediated by parasite-derived proteins on the erythrocyte surface that bind to endothelial receptors. The resulting cerebral babesiosis manifests as neurological signs, including ataxia, circling, and coma. Systemic inflammatory response syndrome (SIRS) occurs due to the release of pro-inflammatory cytokines (TNF-α, IL-1, IL-6) and nitric oxide, leading to vasodilation, hypotension, and disseminated intravascular coagulation (DIC). Hypotension and DIC contribute to multi-organ failure, including acute renal failure, pulmonary edema, and hepatic dysfunction. The spleen plays a crucial role in clearing infected erythrocytes, and splenectomized cattle are particularly susceptible to severe disease. The immune response involves both humoral and cell-mediated mechanisms, with antibodies against merozoite surface antigens and T-cell responses contributing to parasite clearance and immunity.

Intrinsic factors include breed susceptibility (Bos taurus > Bos indicus), age (adults > calves), immune status (naive animals are highly susceptible), and genetic factors affecting resistance to ticks and parasites. Stress factors such as transportation, parturition, lactation, and concurrent diseases can exacerbate clinical severity. Extrinsic factors include high tick infestation levels, environmental conditions favorable for tick survival (warm, humid climates), lack of tick control measures, and introduction of susceptible cattle into endemic areas. Management practices such as grazing on tick-infested pastures, inadequate acaricide application, and failure to quarantine new animals increase the risk of outbreaks. In dairy herds, high milk production and metabolic stress during early lactation may increase susceptibility. Poor nutrition and concurrent infections (e.g., anaplasmosis, theileriosis) can also worsen the outcome.

The incubation period is typically 1-3 weeks after tick attachment, but can be shorter in acute cases. The clinical signs vary depending on the Babesia species and the immune status of the animal. In peracute cases, animals may be found dead without premonitory signs. Acute babesiosis is characterized by a sudden onset of high fever (40-42°C), depression, anorexia, and a sharp drop in milk production. The mucous membranes become pale (anemia) and later icteric (jaundice). Hemoglobinuria is a classic sign, with urine turning dark red to brown. The pulse and respiratory rates are elevated, and animals may show signs of weakness, muscle tremors, and ataxia. In Babesia bovis infections, neurological signs may develop due to cerebral sequestration, including circling, head pressing, nystagmus, convulsions, and coma. Other signs include diarrhea or constipation, ruminal stasis, and dehydration. In chronic cases, animals may show progressive weight loss, intermittent fever, and persistent anemia. Pregnant cows may abort. In endemic areas, calves often show only mild fever and transient anemia, developing premunity. The disease can be fatal within 24-48 hours in severe cases, especially if untreated.

Differential diagnoses include other causes of hemolytic anemia and hemoglobinuria in cattle: 1) Anaplasmosis (Anaplasma marginale) - causes anemia and jaundice but no hemoglobinuria; blood smear shows marginal bodies in erythrocytes. 2) Bacillary hemoglobinuria (Clostridium haemolyticum) - causes sudden death, hemoglobinuria, and liver infarcts; often associated with liver fluke infection. 3) Leptospirosis (Leptospira interrogans serovar Hardjo) - causes fever, anemia, hemoglobinuria, and abortion; serology and dark-field microscopy can confirm. 4) Theileriosis (Theileria parva) - causes fever, lymphadenopathy, and pulmonary edema; schizonts in lymphocytes on blood smear. 5) Post-parturient hemoglobinuria - occurs in high-producing dairy cows after calving, associated with hypophosphatemia; no fever, and blood smear negative for parasites. 6) Copper toxicity - causes hemolytic crisis and jaundice; history of excessive copper supplementation. 7) Water intoxication or onion poisoning - rare causes of hemolysis. 8) Bacillary hemoglobinuria and leptospirosis can be differentiated by history, liver function tests, and specific diagnostic tests. Definitive diagnosis of babesiosis is based on blood smear examination and PCR.

The diagnostic approach should be systematic: 1) Herd history: assess tick exposure, recent introduction of cattle, previous outbreaks, and vaccination status. 2) Physical examination: check for fever, pale/icteric mucous membranes, hemoglobinuria, and neurological signs. 3) Blood smear: collect blood from the ear tip or tail vein, prepare thin and thick smears, stain with Giemsa or Wright's stain, and examine under oil immersion for intraerythrocytic piroplasms. Babesia bigemina appears as large paired pear-shaped organisms, while Babesia bovis appears as small ring forms. 4) Hematology: complete blood count (CBC) to assess anemia (decreased PCV, hemoglobin, RBC count) and thrombocytopenia. 5) Biochemistry: elevated bilirubin (total and indirect), blood urea nitrogen (BUN) and creatinine (if renal failure), and elevated liver enzymes (AST, GGT). 6) Urinalysis: hemoglobinuria (positive for hemoglobin but no red blood cells on sediment). 7) Serology: ELISA or indirect immunofluorescence antibody (IFA) tests to detect antibodies, useful for herd screening and epidemiological studies. 8) Molecular diagnosis: PCR or quantitative PCR (qPCR) for detection of Babesia DNA in blood, highly sensitive and specific, especially in carrier animals. 9) Post-mortem examination: in fatal cases, necropsy reveals pale, icteric carcass, splenomegaly, hepatomegaly, and hemoglobin-stained kidneys. Brain smears in Babesia bovis cases show capillary congestion with infected erythrocytes. 10) Rule out other causes of hemolysis as listed in differential diagnoses.

Hematology: Marked anemia with decreased PCV (often <15%), hemoglobin (Hb) <6 g/dL, and red blood cell (RBC) count <3 x 10^6/μL. Reticulocytosis may be present in recovering animals. Thrombocytopenia is common, especially in Babesia bovis infections. Leukopenia may be seen initially, followed by leukocytosis with a left shift. Biochemistry: Elevated total bilirubin (predominantly unconjugated) due to hemolysis; elevated liver enzymes (aspartate aminotransferase, gamma-glutamyl transferase) due to hepatic hypoxia; elevated blood urea nitrogen and creatinine if renal failure occurs; decreased serum albumin due to protein-losing nephropathy; elevated lactate dehydrogenase. Urinalysis: Hemoglobinuria (positive for hemoglobin on dipstick, but no red blood cells on microscopic examination); bilirubinuria may be present. Blood gas and electrolytes: Metabolic acidosis may develop due to lactic acidosis from tissue hypoxia; hyperkalemia may occur due to hemolysis and renal failure. Coagulation profile: Prolonged prothrombin time and activated partial thromboplastin time, elevated fibrin degradation products, and decreased fibrinogen in cases of DIC. Blood smear: Intraerythrocytic parasites are the definitive finding; Babesia bigemina is large (4-5 μm) and often paired, while Babesia bovis is small (1-2 μm) and ring-shaped. Parasitemia can be as high as 10-30% in Babesia bigemina infections, but lower in Babesia bovis due to sequestration.

Imaging is not commonly used for diagnosis of babesiosis, but may be helpful to assess complications. Ultrasonography: Abdominal ultrasound may reveal splenomegaly (enlarged spleen) and hepatomegaly (enlarged liver) with increased echogenicity. In cases of cerebral babesiosis, transorbital or transcranial ultrasound is not practical. Thoracic ultrasound may show pulmonary edema or pleural effusion in severe cases. Radiography: Not typically used. Endoscopy/Laparoscopy: Not indicated. In summary, imaging has limited diagnostic value for babesiosis; laboratory tests are the mainstay.

Cytology: Blood smears are the primary cytological diagnostic tool, showing intraerythrocytic parasites. In Babesia bovis infections, brain smears (from post-mortem) may show capillary congestion with infected erythrocytes. Histopathology: Post-mortem findings include: 1) Spleen: marked congestion, erythrophagocytosis, and lymphoid depletion. 2) Liver: centrilobular necrosis, bile stasis, and Kupffer cell hyperplasia with hemosiderin deposition. 3) Kidneys: tubular necrosis, hemoglobin casts, and interstitial nephritis. 4) Brain (in Babesia bovis): capillary congestion with infected erythrocytes, perivascular edema, and microhemorrhages. 5) Lungs: pulmonary edema and congestion. 6) Bone marrow: erythroid hyperplasia in chronic cases. These findings are characteristic but not pathognomonic; definitive diagnosis requires demonstration of parasites.

Treatment should be initiated immediately upon suspicion or diagnosis. The primary goals are to eliminate the parasite and provide supportive care. Antiprotozoal drugs: 1) Imidocarb dipropionate (Imizol) is the drug of choice; dose: 1.2 mg/kg SC or IM, repeated once after 24 hours for Babesia bigemina; for Babesia bovis, 2.4 mg/kg SC or IM, repeated once after 48 hours. It is highly effective but has a narrow therapeutic index; side effects include salivation, diarrhea, and transient renal damage. Withdrawal times: meat 28 days, milk 4 days (check label). 2) Diminazene aceturate (Berenil) is an alternative; dose: 3.5 mg/kg IM, once; may be repeated after 24 hours if needed. It is less effective against Babesia bovis. Withdrawal times: meat 21 days, milk 3 days. 3) Tetracyclines (e.g., oxytetracycline) have some babesiacidal activity but are less effective; dose: 10 mg/kg IV or IM, once daily for 3-5 days. Supportive care: 1) Fluid therapy: IV isotonic fluids (e.g., lactated Ringer's solution) to correct dehydration and maintain renal perfusion; in severe anemia, blood transfusion may be necessary (collect blood from a healthy donor, cross-match if possible, administer 4-6 L IV). 2) Anti-inflammatory drugs: Flunixin meglumine (1.1-2.2 mg/kg IV) or meloxicam (0.5 mg/kg IV or SC) to reduce fever and inflammation. 3) Nutritional support: Provide high-quality feed and ensure adequate water intake. 4) In cases of cerebral babesiosis, mannitol (0.5-1 g/kg IV) may be used to reduce cerebral edema. 5) Monitor for complications such as renal failure and DIC; treat accordingly. 6) Tick control: Treat the animal and herd with an acaricide to prevent further tick transmission.

The prognosis is guarded to poor in severe cases, especially if treatment is delayed. Factors indicating a poor prognosis include: 1) Very low PCV (<10%), 2) Severe neurological signs (cerebral babesiosis), 3) Renal failure (elevated BUN/creatinine), 4) DIC, 5) Pregnancy (abortion risk), 6) Concurrent infections. With early treatment, recovery is possible, but convalescence may take several weeks. Milk production may not return to pre-disease levels in the current lactation. In endemic areas, recovered animals develop immunity and become carriers, but may suffer from chronic ill-thrift. Mortality rates can be as high as 50-90% in susceptible adult cattle if untreated. Long-term reproductive performance may be affected due to abortion and ovarian dysfunction.

After treatment, animals should be monitored daily for 7-10 days for clinical improvement (temperature, mucous membrane color, urine color, appetite). Serial PCV and blood smears should be performed every 2-3 days to assess response to therapy and clearance of parasites. If parasitemia persists, repeat treatment may be necessary. In herds, implement tick control measures (regular acaricide application, pasture rotation, and vaccination if available). Quarantine new animals and test for carrier status using PCR. In endemic areas, consider vaccination with live attenuated vaccines (e.g., Babesia bovis and B. bigemina vaccines) to induce premunity. Monitor milk production and reproductive performance in recovered cows. Provide nutritional support and minimize stress during recovery.

Pearls: 1) In endemic areas, calves under 6 months are often protected by maternal antibodies; do not treat them unless clinical signs are severe. 2) Blood smear from the ear tip is more likely to show Babesia bovis due to capillary sequestration. 3) Imidocarb is the most effective drug; use the higher dose for Babesia bovis. 4) Blood transfusion can be life-saving in severely anemic animals (PCV <12%). 5) Always consider babesiosis in any febrile, anemic cow with hemoglobinuria in a tick-endemic area. Pitfalls: 1) Do not confuse hemoglobinuria with hematuria; check urine sediment for red blood cells. 2) Do not use corticosteroids as they may exacerbate the disease. 3) Avoid using tetracyclines as the sole treatment; they are not reliably effective. 4) Do not delay treatment pending laboratory confirmation; start treatment based on clinical signs and blood smear. 5) Be aware of the side effects of imidocarb (cholinergic effects); atropine can be used to counteract severe salivation and diarrhea. 6) In cerebral babesiosis, do not use flunixin meglumine if there is a risk of renal failure; consider alternative anti-inflammatories.

Based on Plumb's Veterinary Drug Handbook and AABP guidelines: 1) Imidocarb dipropionate: 1.2 mg/kg SC or IM for Babesia bigemina; 2.4 mg/kg SC or IM for Babesia bovis; repeat after 24-48 hours. Withdrawal: meat 28 days, milk 4 days. 2) Diminazene aceturate: 3.5 mg/kg IM once; may repeat after 24 hours. Withdrawal: meat 21 days, milk 3 days. 3) Oxytetracycline: 10 mg/kg IV or IM once daily for 3-5 days (as adjunct). Withdrawal: meat 28 days, milk 4 days. 4) Flunixin meglumine: 1.1-2.2 mg/kg IV once daily for up to 3 days. Withdrawal: meat 4 days, milk 36 hours. 5) Meloxicam: 0.5 mg/kg IV or SC once. Withdrawal: meat 15 days, milk 5 days. 6) Supportive fluids: Isotonic crystalloids (e.g., lactated Ringer's) at 40-60 mL/kg/day IV. 7) Blood transfusion: 4-6 L of whole blood from a healthy donor, administered slowly IV. 8) In cerebral cases, mannitol: 0.5-1 g/kg IV over 20-30 minutes. 9) Atropine: 0.04 mg/kg IV or IM to counteract imidocarb side effects if severe. 10) Always follow label directions and consult with a veterinarian for specific protocols.

Key studies and reviews: 1) Bock et al. (2004) 'Babesiosis of cattle' in Parasitology, provides a comprehensive review of epidemiology, pathogenesis, and control. 2) de Vos et al. (2004) 'Babesia bigemina and Babesia bovis' in Veterinary Research, discusses vaccine development and immunity. 3) Mosqueda et al. (2012) 'Current advances in the diagnosis and treatment of bovine babesiosis' in Veterinary Parasitology, reviews diagnostic tools and treatment options. 4) A meta-analysis by Jonsson et al. (2008) on the economic impact of babesiosis in Australia, highlighting production losses. 5) The AABP (American Association of Bovine Practitioners) guidelines on tick-borne diseases recommend integrated tick control and vaccination in endemic areas. 6) Studies on imidocarb efficacy show high cure rates (90-100%) when administered early. 7) Research on live vaccines (e.g., 'Babesia bovis' and 'B. bigemina' vaccines) demonstrates significant reduction in clinical disease and mortality in endemic regions. 8) Recent advances in PCR-based diagnostics have improved detection of carrier animals, aiding in control programs. 9) A study by Suarez et al. (2019) on the molecular basis of Babesia bovis sequestration provides insights into vaccine targets. 10) The World Organisation for Animal Health (OIE) Terrestrial Manual provides standardized diagnostic techniques and vaccine recommendations.